Elevation in inflammatory serum biomarkers predicts response to trastuzumab-containing therapy.
Alkhateeb AA, Leitzel K, Ali SM, Campbell-Baird C, Evans M, Fuchs EM, Köstler WJ, Lipton A, Connor J. Elevation in inflammatory serum biomarkers predicts response to trastuzumab-containing therapy. PLoS One. 2012; 7(12):e51379.